Indiana University School of Medicine

What Indiana University School of Medicine does

Indiana University School of Medicine is the largest medical school in the United States, operating nine campuses across Indiana and enrolling approximately 1,460 MD students alongside a broader base of graduate, health professions, and continuing education learners. The institution delivers medical education through its MD Program, Graduate Degrees (MS and PhD), 160+ residency and fellowship programs, and Health Professions undergraduate degrees, supported by 24 clinical and basic science departments. Its research portfolio is anchored by a top-15 NIH funding ranking among US public medical schools and centers on Alzheimer's disease and related dementias ($370 million in NIH funding 2021-2025, 7th nationally for NIA grants), the Precision Health Initiative ($120 million Grand Challenge spanning five clinical areas), and an NCI-designated Comprehensive Cancer Center. Core research infrastructure includes a Good Manufacturing Practice facility for cellular and gene therapy, Illumina NovaSeq 6000 sequencing systems capable of 200 whole genomes per week, the federally designated National Centralized Repository for Alzheimer Disease (NCRAD) biobank, and the MODEL-AD, TREAT-AD, MPS-AD, and LEADS consortia.

The school's revenue model is a hybrid of medical tuition, federal research grants (NIH, HRSA, NCI, NHLBI, PCORI, HHS), philanthropic donations, and clinical care delivered through a deep partnership with Indiana University Health across statewide facilities. Distribution spans statewide medical education, IU Health clinical services, Project ECHO tele-clinics reaching rural providers, and community outreach programs. AI/ML is deployed as a differentiated clinical and research capability, most notably an open-source dementia detection system combining the Quick Dementia Rating System with a Passive Digital Marker machine learning algorithm that increased ADRD diagnoses by 31% across nine Eskenazi Health federally qualified health centers. Following a leadership transition in July 2026, the school is governed by interim dean Michael Feldman, MD, PhD, while conducting a national search to replace Dean Jay L. Hess, who led the institution for nearly 13 years and grew annual research funding by more than $300 million.

Name

Indiana University School of Medicine

Legal name

Indiana University School of Medicine

Website

https://medicine.iu.edu

Company type

Private

Founded year

1903

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Indiana University School of Medicine is the largest US medical school, operating nine Indiana campuses with 1,460 MD students, 160+ residency programs, and a top-15 NIH-funded research portfolio anchored by Alzheimer's disease and the Precision Health Initiative.

Ownership category

akta.pro rank

Product category

Medical Education

NAICS

Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (6221)

SIC

Services-Health Services (8000), Services-Hospitals (8060)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Schools of Public Health (EDAHAGAD), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Medical education
• Biomedical research
• Graduate medical education
• Clinical research services
• Physician training

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Education Tuition: Revenue from medical school tuition for MD, graduate, and health professions programs across nine campuses
2. NIH and Federal Research Grants: Major research funding from National Institutes of Health including $370 million in Alzheimer's research grants 2021-2025; $515,005 grant from Lilly Endowment for mental health workforce; $5 million HRSA PRIME program grant
3. IU Grand Challenges Program: $120 million Precision Health Initiative investment funding research across five clinical areas
4. Philanthropic Donations: $12.5 million Vera Bradley Foundation donation; ongoing donor contributions through Office of Gift Development
5. Clinical Care Revenue: Revenue from patient care services through IU Health partnership across statewide clinical facilities

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Indiana University School of Medicine is the largest medical school in the United States, providing medical education across nine Indiana campuses through MD, Master's/PhD, Health Professions, and 160+ residency/fellowship programs serving 1,460 medical students. The school operates large-scale NIH-funded biomedical research programs (Alzheimer's disease, cancer, diabetes, traumatic brain injury) and delivers clinical care through its partnership with Indiana University Health.

Product overview

Indiana University School of Medicine is the largest medical school in the United States, offering a comprehensive portfolio of educational programs, research initiatives, and clinical care services across nine Indiana campuses. The core educational offerings include the MD Program, Graduate Degrees (Master's and PhD), Graduate Medical Education (160+ residency and fellowship programs), Health Professions Programs, and Continuing Education. The school's research portfolio centers on key areas of expertise including Alzheimer's Disease (with $370M in NIH funding), Precision Health Initiative ($120M Grand Challenge), and Indiana Health programs addressing opioid crisis and mental health. IU School of Medicine operates specialized research programs including MODEL-AD, TREAT-AD, NCRAD national biobank, and LEADS early-onset Alzheimer's study. The institution also houses the Center for AI and Robotic Excellence in Medicine (CARE) for AI/robotics healthcare applications and offers clinical studies across multiple disease areas. The school is ranked 15th among U.S. public medical schools in NIH research funding.

Differentiator

Problem solved

Functional benefit

Products and services

• MD Program

Quantifiable outcome

• 31% increase in Alzheimer's and related dementia diagnoses using AI dual detection approach
• +4 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature7 records

Partnerships

Twelve partnerships are on record, tiered core.

• Eli Lilly and CompanycoreStrategic or Co-development PartnerEli Lilly and Company partners with IU School of Medicine on the Precision Health Initiative and other research collaborations, contributing to the $120M investment in precision health research.
• Regenstrief InstitutecoreStrategic or Co-development PartnerLong-standing research partnership supporting clinical informatics, healthcare data, and collaborative research particularly in Alzheimer's disease and dementia detection AI systems.
• Eskenazi HealthcoreStrategic or Co-development PartnerClinical partner for AI-driven dementia detection research across nine federally qualified health centers; serves as training site for medical students and residents.
• Indiana University HealthcoreStrategic or Co-development PartnerIU Health is the primary clinical partner system; administers CAR T-cell therapies; operates nearby hospital facilities including Riley Hospital for Children and new 16-story 864-bed hospital under construction.
• Indiana CTSI (Clinical and Translational Sciences Institute)coreStrategic or Co-development PartnerStatewide partnership among IU, Purdue University, University of Notre Dame, and Regenstrief Institute supporting clinical and translational research including Watanabe Prize hosting.
• Purdue UniversitycoreStrategic or Co-development PartnerCollaborates on Center for AI and Robotic Excellence in Medicine (CARE) combining IU School of Medicine clinical expertise with Purdue engineering capabilities.
• IU Simon Comprehensive Cancer CentercoreStrategic or Co-development PartnerPart of Precision Health Initiative partners; received NCI comprehensive designation in 2019.
• Vera Bradley Foundation Center for Breast CancercoreStrategic or Co-development PartnerMajor philanthropy supporting breast cancer research; previously donated $12.5 million to IU medical school.
• Beckman Coulter Life SciencescoreStrategic or Co-development PartnerReceived $2.5 million NCI grant in partnership with Beckman Coulter to expand leukemia and lymphoma testing in Western Kenya since 2018.
• Stark Neurosciences Research InstitutecoreStrategic or Co-development PartnerResearch institute focusing on brain and nervous system diseases including Alzheimer's, traumatic brain injury, and spinal cord injury.
• Brown Center for ImmunotherapycoreStrategic or Co-development PartnerPart of Precision Health Initiative supporting CAR T-cell therapy development and administration.
• Rehabilitation Hospital of IndianacoreStrategic or Co-development PartnerDesignated Traumatic Brain Injury Model Systems Site (one of 16 in nation) focusing on long-term treatment and rehabilitation research.

Scale indicators15 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Ohio State University College of Medicine: Large public medical school in the Big Ten with extensive NIH funding and statewide campus model. Most directly comparable to IUSM in mission, scale, public-university structure, and Midwest geography.
• University of Michigan Medical School: Top-10 NIH-funded public medical school where former IUSM Dean Jay L. Hess previously served. Closely comparable in research intensity, public-university status, and translational research portfolio.
• University of Illinois College of Medicine: Largest medical school in the U.S. by enrollment prior to IUSM, also operating a multi-campus urban/rural model in Illinois. Closely parallels IUSM's nine-campus statewide distribution strategy.
• University of Wisconsin School of Medicine and Public Health: Big Ten public medical school integrating medicine and public health — directly comparable to IUSM's Indiana Health programs and population-health focus.
• University of Minnesota Medical School: Upper-Midwest public medical school with dual-campus (Twin Cities/Duluth) model and strong NIH research portfolio. Comparable in geographic distribution and rural-health mission.
• University of Florida College of Medicine: Large public medical school with comparable NIH funding scale, statewide campus network (Gainesville/Jacksonville), and similar translational research infrastructure.
• University of Pittsburgh School of Medicine: Top-5 NIH-funded public medical school with strong Alzheimer's and translational research portfolio, comparable in scale and federal research-grant capture.

Broad incumbents

• Washington University School of Medicine in St. Louis: Top-5 NIH-funded U.S. medical school with elite Alzheimer's research (Knight ADRC, Dominantly Inherited Alzheimer Network). Comparable Alzheimer's translational pipeline but private and significantly better-funded.
• Johns Hopkins University School of Medicine: Top-ranked U.S. medical school and the source of IUSM Dean Hess's MD/PhD. Comparable in NIH funding scale and translational research, but private and considerably larger.

Others

• Purdue University (College of Engineering / Weldon School): IUSM's core strategic partner for the Center for AI and Robotic Excellence in Medicine (CARE). Adjacent but enabling — provides engineering and AI capability that complements IUSM's clinical expertise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/iumedschool
• Facebookfacebook.com/IUMedicine
• LinkedInlinkedin.com/company/indiana-university-school-of-medicine
• Instagraminstagram.com/iumedschool

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds12 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indiana University School of Medicine